Mumbai, Sept. 21 -- ERIS Lifesciences has appointed Akhil Awasthi (DIN: 00148350) as an Additional Director (Non-executive, Independent) of the Company for a term of five years, effective from 26 September 2026, subject to the approval of the members.

Published by HT Digital Content Services with permission from Capital Market....